Sir, Bacterial endocarditis is a frequent complication of intravenous (i.v.) drug misuse often associated with a significant mortality and morbidity. Staphylococcus aureus is the commonest infecting organism, usually presenting as a 'pneumonia' or septicaemia and with no or minimal cardiac murmurs.1 However, other pathogens, especially skin derived streptococci, are important and serious causes of endocarditis in this group of patients. In fact, P-haemolytic streptococci Group G produce a highly invasive and destructive endocarditis associated with a 36% mortality. 2 Drug users admitted to hospital with clinical features suggestive of endocarditis are often commenced on antimicrobial therapy on a best guess basis. The following case, which illustrates an uncommon mixed infection, highlights the importance of initially using a combination of benzylpenicillin in high doses, flucloxacillin and an aminoglycoside, until culture and sensitivity results are available, to ensure that broad cover effective therapy is instigated early.
A 29 year old intravenous drug user was admitted with a one week history of fever, rigors, headaches, pleuritic chest pain and a cough productive of purulent sputum. His temperature was 39C. He had a loud systolic murmur maximal at the left sternal edge and bilateral basal pleural rubs. Echocardiography did not reveal any vegetations (as in up to 70% of cases of infective endocarditis).3
A provisional diagnosis of a right sided bacterial endocarditis was made. Empirical therapy with flucloxacillin and gentamicin was commenced. Twenty four hours following admission coagulase positive Staphylococcus aureus was isolated in two sets of cultures. A further 48 hours later beta haemolytic streptococcus (serotype group G) was also isolated. At this stage there was evidence of gentamicin-induced nephrotoxicity despite monitoring of serum levels. The regime was changed to i.v. benzylpenicillin, ciprofloxacin and flucloxacillin. Penicillin and the latter combination were found to be satisfactorily bacteriocidal to the streptococcus and staphylococcus respectively. Regrettably the patient took his own discharge 18 days after admission.
As this case shows, drug using patients are notoriously difficult to treat as inpatients for the recommended period of4 to 6 weeks. Recently, a shorter two week regime using nafcillin-tobramycin was shown to be effective. 4 Finally there is increasing evidence that ciprofloxacin may be an effective alternative treatment for staphylococcal endocarditis.5 This may allow treatment to be continued on an outpatient basis in those patients refusing to remain in hospital. It 
